Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02640833
Title A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie

chronic lymphocytic leukemia/small lymphocytic lymphoma


Duvelisib + Venetoclax

Age Groups: adult
Covered Countries USA

No variant requirements are available.